CXCL9 (74-103)

CAT: 0013-GTR19144408-01Size: 50 mgDry Ice: NoHazardous: No

1 / 1

CAT#:0013-GTR19144408-01Size:50 mg

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

CXCL9 (74-103) is a derivative peptide of CXCL9 that binds with high affinity to glycosaminoglycans (GAGs) . It exhibits anti-angiogenic properties by reducing angiogenesis mediated by EGF, VEGF165, and FGF-2 in vitro, without causing cytotoxicity.

Field of Research

Cell Biology, Immunology & Inflammation, Pharmacology & Drug Discovery

Storage Conditions

-20°C

Notes

For research use only.

Related Products

Catalog	Name
GTR18027008	74 Antibody
GTR19235161-01	HSD17B13-IN-74
GTR19211683-01	HT-74
GTR19034996-01	Oligopeptide-74
GTR19212339-01	EGFR-IN-74
GTR19036774-01	Peptide 74
GTR19238633-01	α-Glucosidase-IN-74
GTR19236397-01	HDAC-IN-74
GTR19219499	FAPI-74
GTR19198351-01	AB 74

Alternative Products

Catalog	Name
TP3529-01	CXCL9 (74-103)
045-62	CXCL9 / MIG (74-103) (Human)
045-63	CXCL9 / MIG (77-103) (Human)
P-9099	PI-103, Free Base [CAS# 371935-74-9]
559724-01	CXCL9
048443	CXCL9 (Novimmune patent CXCL9) discontinued
HY-173294	NLRP3-IN-74
T210070-01	AChE-IN-74
HY-157723	HSD17B13-IN-74
P3281-07	Peptide 74

CXCL9 (74-103)

Related Products

Alternative Products

Popular Products